Highlights and Quick Summary
- Annual 3Y Shareholders Equity Growth (per Share) for 2022 was 10.65% (a -124.8% decrease from previous year)
- Annual 3Y Shareholders Equity Growth (per Share) for 2021 was -42.95% (a -22.57% decrease from previous year)
- Annual 3Y Shareholders Equity Growth (per Share) for 2020 was -55.47% (a 2.46% increase from previous year)
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 3Y Shareholders Equity Growth (per Share) of Precigen, Inc.
Most recent 3Y Shareholders Equity Growth (per Share)of PGEN including historical data for past 10 years.Interactive Chart of 3Y Shareholders Equity Growth (per Share) of Precigen, Inc.
Precigen, Inc. 3Y Shareholders Equity Growth (per Share) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | 10.65% |
| 2021 | – | – | – | – | -42.95% |
| 2020 | – | – | – | – | -55.47% |
| 2019 | – | – | – | – | -54.14% |
| 2018 | – | – | – | – | -22.77% |
| 2017 | – | – | – | – | 3.34% |
| 2016 | – | – | – | – | -19.68% |
| 2015 | – | – | – | – | -25.55% |
| 2014 | – | – | – | – | -35.45% |
| 2013 | – | – | – | – | 24.51% |
| 2012 | – | – | – | – | 34.32% |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology